Cisen Pharma is an integrated chemical pharmaceutical Co.,Ltd., which was founded on 1970 and listed on main board of SGX 2017. Our products cover the seven following dosage form: LVP\SVP\OSD\Lyophilized PFI(Including PFI)\External Use Product\API\ FSMP(Food for Special Medical Purpose). The following eight therapuetic area: Parenteral Nutrition, Antineoplastic, CVD, Digestive system, Diabetes, Respiratory System, Anesthesia and its aid, Anti-depression are included. External use product, such as eye drop, ointment, cream, aseptic eye ointment；API: Heparin Sodium;Enoxaparin Sodium;Dexmedetomidine HCL and so on.
Year Established: 1970
Total Assets(USD): 500,000 to 99,999,999
Total Number of Staff: more than 1000
Main Competitive Advantages: Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
Business Type: Manufacturer
R&D Capacity: OEM
Annual Turnover(USD) : 500,000 to 99,999,999
Main Sales Markets : Central/South America,Asia,Middle East,Africa
Subscribe to the latest newsletter of Virtual Expo Connect
mepivacaine hydrochloride injection
Lansoprazole for Injection
Vecuronium Bromide for Injection
Gemcitabine for Injection
